Top Publicly-traded Longevity Stocks
| # | Stock | Price | Marketcap | Chart (5D) | Volume | Last Updated |
|---|---|---|---|---|---|---|
| $13.81 (-0.65%) | $2.33B | 1.77M | 3 days ago | |||
 Grifols, S.A. GRFS | $12.63 (+4.55%) | $11.54B | 657.83K | 3 days ago | ||
 Denali Therapeutics DNLI | $34.84 (+2.89%) | $4.25B | 1.11M | 3 days ago | ||
 Celularity CELU | $4.14 (-2.13%) | $511.14M | 69.11K | 3 days ago | ||
| $4.63 (-1.28%) | $617.50M | 84.48K | 3 days ago | |||
 Humacyte HUMA | $5.83 (+1.22%) | $600.51M | 414.39K | 3 days ago | ||
 ALX Oncology ALXO | $18.50 (+0.38%) | $749.24M | 873.49K | 3 days ago | ||
 Alector ALEC | $17.51 (+2.58%) | $1.42B | 474.23K | 3 days ago | ||
| $4.66 (+0.00%) | $116.14M | 59.17K | 3 days ago | |||
| $5.14 (-0.96%) | $177.86M | 195.45K | 3 days ago | |||
 Scholar Rock SRRK | $20.23 (+1.76%) | $710.24M | 243.34K | 3 days ago | ||
 Athersys ATHX | $0.8765 (+6.37%) | $206.18M | 1.22M | 3 days ago | ||
| $1.48 (+4.96%) | $85.43M | 514.34K | 3 days ago | |||
| $1.89 (+2.72%) | $318.57M | 1.04M | 3 days ago | |||
 GENSIGHT BIOLOGICS SIGHT.PA | 5,37 € (+3.87%) | $281.36M | 143,01 K | 6 hours ago | ||
| $0.9000 (+4.01%) | $51.82M | 79.50K | 3 days ago | |||
 CohBar CWBR | $0.3650 (-1.35%) | $31.41M | 518.81K | 3 days ago | ||
 Organovo ONVO | $3.74 (-0.27%) | $32.56M | 24.95K | 3 days ago | ||
 Longeveron LGVN | $9.08 (+3.06%) | $189.33M | 780.26K | 3 days ago | ||
 BIOPHYTIS ALBPS.PA | 0,4485 € (-1.62%) | $66.02M | 625,28 K | 6 hours ago | ||
| $0.8200 (-12.49%) | $31.11M | 408.52K | 3 days ago | |||
 ENDURANCE RP 0575.HK | $0.1490 (+2.76%) | $45.89M | 2.79M | 15 hours ago | ||
 ChromaDex CDXC | $3.01 (-2.90%) | $205.56M | 646.24K | 3 days ago |
*Stock price data delayed by up to 15 minutes. Information is provided “as is”. Not for trading purposes or advice.
Sponsored
The first longevity industry jobs board, company directory, and investor list.
Latest Posts
Longevity Marketcap Newsletter
- #037: Jan 11th, 2022 - Longevity Marketcap Newsletter January 11, 20222021 Industry Review. NewLimit. New Funds. Longevity Biotech Job Fair.
- #036: Oct 25th, 2021 - Longevity Marketcap Telemetry October 26, 2021Altos Labs. ODX. Impetus Grants. Healthspan Capital. Media is Code.
- Longevity Resources [updated Aug 13, 2021] August 13, 2021Here’s a list of longevity science and industry resources to get you started. If you have any suggestions please leave them in the comments belo…
- #035: July 6th, 2021 - Longevity Marketcap Telemetry July 7, 2021On Deck Longevity Biotech. VitaDAO raise. Insilico Medicine, Continuum Biosciences, Vita Therapeutics. Mystery non-profit. Adventures in longevity.
- #034: June 9th, 2021 - Longevity Marketcap Telemetry June 10, 2021Aducanumab! VitaDAO token sale. Lineage Cell. Non-Traditional.
- Non-Traditional June 9, 2021You don't need formal biology training to get involved in longevity. Here are some examples of leaders and founders working on aging that came from "non-traditional" backgrounds.
- #033: May 27th, 2021 - Longevity Marketcap Telemetry May 28, 2021Oisin and Loyal seed rounds. HAYA stealth. How to start a longevity biotech company.
- #032: May 18th, 2021 - Longevity Marketcap Telemetry May 19, 2021Seismic funding rumors. Unity passes Phase 1. Deciduous Tx. Apprentices and Whitepapers. Humans for Longevity.
- #031: May 10th, 2021 - Longevity Marketcap Telemetry May 11, 2021Michael Greve's €300M commitment. Dyno / Stealth / FOXO. Thoughts on what the aging field needs.
- #030: May 4th, 2021 - Longevity Marketcap Telemetry May 5, 2021Turn Bio funding. Unity Biotechnology and Denali Therapeutics updates. The Cost of Aging.